Insider Transactions in Q4 2023 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2023
|
Jeremy T Grant |
BUY
Grant, award, or other acquisition
|
Direct |
11,768
+35.0%
|
-
|
|
Nov 21
2023
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
1,378
-0.41%
|
$13,780
$10.29 P/Share
|
|
Nov 20
2023
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,804
-0.98%
|
$158,040
$10.37 P/Share
|
|
Nov 20
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
12,630
-3.64%
|
$126,300
$10.37 P/Share
|
|
Nov 20
2023
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
7,363
-2.58%
|
$73,630
$10.37 P/Share
|
|
Nov 20
2023
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,187
-2.36%
|
$61,870
$10.37 P/Share
|
|
Nov 20
2023
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
7,982
-2.34%
|
$79,820
$10.37 P/Share
|
|
Nov 14
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,482
-0.71%
|
$24,820
$10.22 P/Share
|
|
Oct 30
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+4.12%
|
-
|
|
Oct 16
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,482
-0.74%
|
$22,338
$9.03 P/Share
|